Suppliers / Cpl Pharmaceuticals

Cpl Pharmaceuticals

India Updated 9 July 2026

Cpl Pharmaceuticals is an API manufacturer based in India. It holds 4 valid CEPs across a filed portfolio of 3 molecules.

0
active US DMFs
4
valid CEPs
1
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Ahmedabad, India Not on file

What they file, and where

Molecule Regulators Docs
Olmesartan Medoxomil EDQM 2
Irbesartan EDQM 1
Valsartan EDQM 1

Also appears on these molecule pages

Questions about Cpl Pharmaceuticals

Does Cpl Pharmaceuticals hold a US DMF or a CEP?
Cpl Pharmaceuticals holds 4 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Cpl Pharmaceuticals manufacture?
1 registered site is on record, in India (Ahmedabad). Every site is listed on this page with the register it came from.
What does Cpl Pharmaceuticals make?
3 molecules are on record against Cpl Pharmaceuticals, including Olmesartan Medoxomil, Irbesartan and Valsartan. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Cpl Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability